mitoxantrone has been researched along with Cancer of the Urinary Tract in 3 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Excerpt | Relevance | Reference |
---|---|---|
"The relative increased risk of breast cancer in MS women under IS treatment warrants further attention." | 1.35 | Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis. ( Berthier, F; Clavelou, P; Danzon, A; de Seze, J; Debouverie, M; Defer, G; Gout, O; Lebrun, C; Rumbach, L; Vermersch, P; Wiertlevski, S, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kirsch, M | 1 |
Weisse, C | 1 |
Berent, A | 1 |
Clifford, C | 1 |
Leibman, N | 1 |
Wittenburg, L | 1 |
Solomon, SB | 1 |
Lamb, K | 1 |
Lebrun, C | 1 |
Debouverie, M | 1 |
Vermersch, P | 1 |
Clavelou, P | 1 |
Rumbach, L | 1 |
de Seze, J | 1 |
Wiertlevski, S | 1 |
Defer, G | 1 |
Gout, O | 1 |
Berthier, F | 1 |
Danzon, A | 1 |
Andersen, LJ | 1 |
Sengeløv, L | 1 |
Kamby, C | 1 |
von der Maase, H | 1 |
2 trials available for mitoxantrone and Cancer of the Urinary Tract
Article | Year |
---|---|
Pilot study comparing serum chemotherapy levels after intra-arterial and intravenous administration in dogs with naturally occurring urinary tract tumors.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Carboplatin; Dog Diseases; Dogs; Female; Injection | 2019 |
Cisplatin, methotrexate and mitoxantrone in patients with metastatic or advanced urothelial cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Femal | 1998 |
1 other study available for mitoxantrone and Cancer of the Urinary Tract
Article | Year |
---|---|
Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.
Topics: Adult; Azathioprine; Breast Neoplasms; Central Nervous System Neoplasms; Cyclophosphamide; Digestive | 2008 |